WallStreetZenWallStreetZen

NASDAQ: BDTX
Black Diamond Therapeutics Inc Stock Ownership - Who owns Black Diamond Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Black Diamond Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ali BehbahaniDirector2025-03-217,646$1.88
$14.37kBuy
Prakash RamanDirector2025-03-216,848$1.88
$12.87kBuy
Growth N. V. Biotech10% Owner2025-03-191,000,000$2.07
$2.07MSell
Growth N. V. Biotech10% Owner2025-03-19300,000$1.94
$582.90kSell
Growth N. V. Biotech10% Owner2025-03-191,000,000$2.31
$2.31MSell
Growth N. V. Biotech10% Owner2025-03-192,000,000$2.00
$4.00MSell
Growth N. V. Biotech10% Owner2025-03-19584,292$1.95
$1.14MSell
Growth N. V. Biotech10% Owner2025-03-19400,000$2.09
$837.20kSell
Growth N. V. Biotech10% Owner2025-03-19500,000$2.12
$1.06MSell
Prakash RamanDirector2024-12-135,150$2.50
$12.88kBuy

1 of 2

BDTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BDTX insiders and whales buy or sell their stock.

BDTX Shareholders

What type of owners hold Black Diamond Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
T Rowe Price Investment Management Inc18.47%10,466,721$16.75MInstitution
Ali Behbahani15.83%8,968,494$14.35MInsider
Bellevue Group Ag15.03%8,517,839$13.63MInstitution
Vestal Point Capital LP9.88%5,600,000$8.96MInstitution
Versant Venture Capital VI LP8.03%4,548,481$7.28MInsider
Nea Management Company LLC7.85%4,448,757$7.12MInstitution
Blackrock Inc6.21%3,519,145$5.63MInstitution
Growth N. V. Biotech4.82%2,733,547$4.37MInsider
Vanguard Group Inc4.26%2,413,941$3.86MInstitution
Tang Capital Management LLC3.65%2,070,209$3.31MInstitution

1 of 3

BDTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BDTX70.39%29.61%Net SellingNet Selling
PLRX71.14%28.86%Net Selling
VTYX45.90%54.10%Net BuyingNet Selling
TCRX73.39%25.38%Net Buying
VIGL41.59%58.41%Net Buying
View Top Biotech Stocks

Black Diamond Therapeutics Stock Ownership FAQ

Who owns Black Diamond Therapeutics?

Black Diamond Therapeutics (NASDAQ: BDTX) is owned by 84.55% institutional shareholders, 35.57% Black Diamond Therapeutics insiders, and 0.00% retail investors. Ali Behbahani is the largest individual Black Diamond Therapeutics shareholder, owning 8.97M shares representing 15.83% of the company. Ali Behbahani's Black Diamond Therapeutics shares are currently valued at $14.35M.

If you're new to stock investing, here's how to buy Black Diamond Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.